Noninvasive PK11195‐PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease
暂无分享,去创建一个
Jenna M. Sullivan | P. Mozley | S. Vallabhajosula | D. Schlyer | P. Chiao | J. Logan | S. Gauthier | Yeona Kang | C. Henchcliffe | K. Pryor | J. Hesterman | A. Nikolopoulou | Ajay Verma | P. Kothari | Bin He
[1] J. Fleiss,et al. Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.
[2] O. Inoue,et al. Synthesis and evaluation of11C-PK 11195 forin vivo study of peripheral-type benzodiazepine receptors using position emission tomography , 1989 .
[3] O. Inoue,et al. Synthesis and evaluation of 11C-PK 11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography. , 1989, Annals of nuclear medicine.
[4] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[5] S. Hume,et al. Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. , 1994, Nuclear medicine and biology.
[6] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[7] N. Volkow,et al. Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] J. Logan. Graphical analysis of PET data applied to reversible and irreversible tracers. , 1999, Nuclear medicine and biology.
[9] Roger N Gunn,et al. Positron Emission Tomography Compartmental Models: A Basis Pursuit Strategy for Kinetic Modeling , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] Ronald Boellaard,et al. Development of a Tracer Kinetic Plasma Input Model for (R)-[11C]PK11195 Brain Studies , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] Alexander Hammers,et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease , 2006, Neurobiology of Disease.
[12] F. Turkheimer,et al. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] Tuula Tolvanen,et al. Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[14] Sarah H Lisanby,et al. Safety of Radial Arterial Catheterization in PET Research Subjects , 2009, Journal of Nuclear Medicine.
[15] Tim Mulnix,et al. A multimodal approach to image-derived input functions for brain PET , 2009, 2009 IEEE Nuclear Science Symposium Conference Record (NSS/MIC).
[16] M. Goldberg,et al. Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention , 2010, Neurobiology of Disease.
[17] Max A. Viergever,et al. elastix: A Toolbox for Intensity-Based Medical Image Registration , 2010, IEEE Transactions on Medical Imaging.
[18] Kewei Chen,et al. Image-Derived Input Function for Brain PET Studies: Many Challenges and Few Opportunities , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[19] Ronald Boellaard,et al. Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[11C]PK11195 brain PET studies , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] Roger N Gunn,et al. An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] Christer Halldin,et al. Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects , 2012, EJNMMI Research.
[22] Masahiro Fujita,et al. Population-based input function and image-derived input function for [11C](R)-rolipram PET imaging: Methodology, validation and application to the study of major depressive disorder , 2012, NeuroImage.
[23] B. Lopresti,et al. Molecular imaging of microglia/macrophages in the brain , 2013, Glia.
[24] Torbjörn Falkmer,et al. The Case for Using the Repeatability Coefficient When Calculating Test–Retest Reliability , 2013, PloS one.
[25] Alan A. Wilson,et al. Imaging Striatal Microglial Activation in Patients with Parkinson’s Disease , 2015, PloS one.
[26] Alessandra Bertoldo,et al. The methodology of TSPO imaging with positron emission tomography , 2015, Biochemical Society transactions.
[27] Jia-wei Zhou,et al. Neuroinflammation in Parkinson’s disease and its potential as therapeutic target , 2015, Translational Neurodegeneration.
[28] Drew A. Torigian,et al. Repeatability of 18F-FDG PET/CT in Advanced Non–Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials , 2015, The Journal of Nuclear Medicine.
[29] T. O'Brien,et al. Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases? , 2016, The Journal of Nuclear Medicine.
[30] Sumit Sarkar,et al. Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives , 2016, International journal of molecular sciences.
[31] W. Le,et al. Protective Microglia and Their Regulation in Parkinson’s Disease , 2016, Front. Mol. Neurosci..
[32] Nicholas Petrick,et al. Statistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile Claims. , 2016, Academic radiology.
[33] A. Gerhard. TSPO imaging in parkinsonian disorders , 2016, Clinical and Translational Imaging.
[34] R. Ransohoff. How neuroinflammation contributes to neurodegeneration , 2016, Science.
[35] Hans J. Johnson,et al. Advanced Normalization Tools (ANTs) , 2020 .